Francisco Lozano

7.4k total citations
189 papers, 4.9k citations indexed

About

Francisco Lozano is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Francisco Lozano has authored 189 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Immunology, 38 papers in Molecular Biology and 33 papers in Oncology. Recurrent topics in Francisco Lozano's work include Immune Cell Function and Interaction (50 papers), T-cell and B-cell Immunology (48 papers) and Monoclonal and Polyclonal Antibodies Research (29 papers). Francisco Lozano is often cited by papers focused on Immune Cell Function and Interaction (50 papers), T-cell and B-cell Immunology (48 papers) and Monoclonal and Polyclonal Antibodies Research (29 papers). Francisco Lozano collaborates with scholars based in Spain, United States and France. Francisco Lozano's co-authors include Jordi Vives, Maria‐Rosa Sarrias, Javier Calvo, Olga Padilla, Lourdes Places, Francisco Sánchez‐Madrid, Uffe Holmskov, Reinhard Schwartz‐Albiez, Juan Manuel Serrador and Heinz Furthmayr and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Francisco Lozano

183 papers receiving 4.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francisco Lozano Spain 37 2.7k 1.2k 743 616 577 189 4.9k
Marlene L. Rose United Kingdom 47 2.2k 0.8× 1.1k 0.9× 475 0.6× 636 1.0× 604 1.0× 168 6.4k
Daniel Hanau France 44 4.1k 1.5× 1.7k 1.3× 446 0.6× 814 1.3× 662 1.1× 141 6.4k
Alison Finnegan United States 46 2.8k 1.0× 1.4k 1.2× 993 1.3× 408 0.7× 554 1.0× 91 5.6k
Robert Peach United States 37 3.3k 1.2× 1.3k 1.1× 1.2k 1.7× 258 0.4× 678 1.2× 83 5.9k
Marilyn R. Kehry United States 45 3.8k 1.4× 1.7k 1.4× 856 1.2× 440 0.7× 419 0.7× 95 6.0k
Henri de la Salle France 39 3.5k 1.3× 1.8k 1.4× 573 0.8× 433 0.7× 619 1.1× 104 5.7k
Thierry Defrance France 42 4.6k 1.7× 1.3k 1.1× 962 1.3× 433 0.7× 585 1.0× 85 6.7k
José M. Casasnovas Spain 36 2.8k 1.0× 1.7k 1.4× 1.4k 1.8× 634 1.0× 786 1.4× 77 5.7k
Jordi Vives Spain 34 1.7k 0.6× 1.1k 0.9× 586 0.8× 436 0.7× 414 0.7× 113 3.4k
Paschalis Sideras Sweden 40 4.8k 1.8× 1.8k 1.5× 837 1.1× 336 0.5× 393 0.7× 79 7.3k

Countries citing papers authored by Francisco Lozano

Since Specialization
Citations

This map shows the geographic impact of Francisco Lozano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francisco Lozano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francisco Lozano more than expected).

Fields of papers citing papers by Francisco Lozano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francisco Lozano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francisco Lozano. The network helps show where Francisco Lozano may publish in the future.

Co-authorship network of co-authors of Francisco Lozano

This figure shows the co-authorship network connecting the top 25 collaborators of Francisco Lozano. A scholar is included among the top collaborators of Francisco Lozano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francisco Lozano. Francisco Lozano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Isamat, Marcos, et al.. (2025). The Human Mycobiome: Composition, Immune Interactions, and Impact on Disease. International Journal of Molecular Sciences. 26(15). 7281–7281.
2.
Dematteis, Sylvia, et al.. (2024). Recombinant CD5 and CD6 Ectodomains Induce Antiparasitic and Immunomodulatory Effects in Secondary Cystic Echinococcosis. Parasite Immunology. 46(4). e13034–e13034.
3.
Català, Cristina, et al.. (2023). Chimeric antigen receptor–based therapies beyond cancer. European Journal of Immunology. 53(3). e2250184–e2250184. 6 indexed citations
4.
Isamat, Marcos, et al.. (2023). CD6 and Its Interacting Partners: Newcomers to the Block of Cancer Immunotherapies. International Journal of Molecular Sciences. 24(24). 17510–17510. 4 indexed citations
5.
Benítez‐Ribas, Daniel, et al.. (2022). Novel Tumor-Targeted Self-Nanostructured and Compartmentalized Water-in-Oil-in-Water Polyurethane-Polyurea Nanocapsules for Cancer Theragnosis. Pharmaceutics. 15(1). 58–58. 1 indexed citations
6.
Català, Cristina, et al.. (2021). Contribution of Evolutionary Selected Immune Gene Polymorphism to Immune-Related Disorders: The Case of Lymphocyte Scavenger Receptors CD5 and CD6. International Journal of Molecular Sciences. 22(10). 5315–5315. 7 indexed citations
7.
Català, Cristina, et al.. (2020). Soluble CD5 and CD6: Lymphocytic Class I Scavenger Receptors as Immunotherapeutic Agents. Cells. 9(12). 2589–2589. 21 indexed citations
8.
Vásquez, Marcos, Marta Consuegra‐Fernández, Fernando Aranda, et al.. (2019). Treatment of Experimental Autoimmune Encephalomyelitis by Sustained Delivery of Low-Dose IFN-α. The Journal of Immunology. 203(3). 696–704. 7 indexed citations
9.
Retamozo, Soledad, Alejandra Flores-Chávez, Marta Consuegra‐Fernández, et al.. (2017). Cytokines as therapeutic targets in primary Sjögren syndrome. Pharmacology & Therapeutics. 184. 81–97. 22 indexed citations
10.
Bautista-Rodríguez, Carles, Cristian Launes, Iolanda Jordán, et al.. (2017). Mannose-binding lectin-deficient genotypes as a risk factor of pneumococcal meningitis in infants. PLoS ONE. 12(5). e0178377–e0178377. 7 indexed citations
11.
Vásquez, Marcos, et al.. (2017). Exploiting scavenger receptors in cancer immunotherapy: Lessons from CD5 and SR‐B1. European Journal of Immunology. 47(7). 1108–1118. 30 indexed citations
12.
Consuegra‐Fernández, Marta, Mario Martínez‐Florensa, Fernando Aranda, et al.. (2017). Relevance of CD6-Mediated Interactions in the Regulation of Peripheral T-Cell Responses and Tolerance. Frontiers in Immunology. 8. 594–594. 10 indexed citations
13.
Carnero‐Montoro, Elena, M. Luisa Bonet, Johannes Engelken, et al.. (2011). Evolutionary and Functional Evidence for Positive Selection at the Human CD5 Immune Receptor Gene. Molecular Biology and Evolution. 29(2). 811–823. 14 indexed citations
14.
Vera, Jorge, Rafael Fenutría, Olga Cañadas, et al.. (2009). The CD5 ectodomain interacts with conserved fungal cell wall components and protects from zymosan-induced septic shock-like syndrome. Proceedings of the National Academy of Sciences. 106(5). 1506–1511. 115 indexed citations
15.
Gimferrer, Idoia, Anna Ibáñez, Maria‐Rosa Sarrias, et al.. (2005). The Lymphocyte Receptor CD6 Interacts with Syntenin-1, a Scaffolding Protein Containing PDZ Domains. The Journal of Immunology. 175(3). 1406–1414. 44 indexed citations
16.
Arman, Mònica, Javier Calvo, Maria Trojanowska, et al.. (2004). Transcriptional Regulation of Human CD5: Important Role of Ets Transcription Factors in CD5 Expression in T Cells. The Journal of Immunology. 172(12). 7519–7529. 19 indexed citations
17.
Gimferrer, Idoia, Marı́a Calvo, Marı́a Mittelbrunn, et al.. (2004). Relevance of CD6-Mediated Interactions in T Cell Activation and Proliferation. The Journal of Immunology. 173(4). 2262–2270. 118 indexed citations
18.
Calvo, Javier, Lourdes Places, Olga Padilla, et al.. (2001). Role of Two Conserved Cytoplasmic Threonine Residues (T410 and T412) in CD5 Signaling. The Journal of Immunology. 166(1). 396–402. 13 indexed citations
19.
Padilla, Olga, et al.. (2000). The scavenger receptor cysteine-rich superfamily (SRCR-SF). Structure and function of group B members. 105–121. 10 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marlene L. Rose Breakdown of academic impact, for papers by Daniel Hanau Breakdown of academic impact, for papers by Alison Finnegan Breakdown of academic impact, for papers by Robert Peach Breakdown of academic impact, for papers by Marilyn R. Kehry Breakdown of academic impact, for papers by Henri de la Salle Breakdown of academic impact, for papers by Thierry Defrance Breakdown of academic impact, for papers by José M. Casasnovas Breakdown of academic impact, for papers by Jordi Vives Breakdown of academic impact, for papers by Paschalis Sideras
Rankless by CCL
2026